TraceLink Stock

tracelink.comHealthcare / Healthcare softwareFounded: 2009Funding to Date: $139.21MM

TraceLink is a network creation platform company that builds integrated business ecosystems with multienterprise applications, delivering customer-centric agility and resiliency for end-to-end supply networks and leveraging the collective intelligence of entire industries. TraceLink's Opus Platform enables speed of innovation and implementation with an open partner model for no-code and low-code development of solutions and applications. This company was founded in 2009 and is headquartered in North Reading, MA.

Register To Buy and Sell Shares

For more details on financing and valuation for TraceLink, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access TraceLink’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like TraceLink.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Bob Sturim
Chief Technology Officer
Shabbir Dahod
Co-Founder, President, Chief Executive Officer and Board Member
John Kordash
Senior Vice President, Cloud & Chief Information Officer
Daniel Nelson
Chief Information Security Officer
Michael Mozzer
Chief Financial Officer
Paul Cianciolo
Chief Operating Officer

Board Members

Jack Cooper
Shabbir Dahod
Thomas Ebling
Jason Kreuziger
The Goldman Sachs Group
Steven Collins
Amish Jani
FirstMark Capital
Sean Cantwell
Volition Capital
Tyson Baber JD
Georgian Partners

TraceLink’s stock FAQs


Can you buy TraceLink’s stock?

TraceLink is not publicly traded on NYSE or NASDAQ in the U.S. To buy TraceLink’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell TraceLink’s stock?

Yes, you can sell stock of a private company like TraceLink. Forge can help you sell your TraceLink stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is TraceLink’s stock price?

TraceLink is a privately held company and therefore does not have a public stock price. However, you may access TraceLink’s private market stock price with Forge Data.

What is TraceLink’s stock ticker symbol?

TraceLink does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

TraceLink's New Supply Chain Work Management for Direct Supply Integrates All Suppliers and CMOs with a Single Link to Digitalize the Entire Purchase Order Process

BOSTON, Sept. 13, 2022 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company, today announced the availability of Supply Chain Work Management for Direct Supply—the first solution to enable healthcare and life sciences companies to connect and collaborate with all suppliers, including contract manufacturers, in real-time and ensure complete upstream visibility. Supply Chain Work Management for Direct Supply is the fastest and easiest path to supply chain digital transformation for leaders in Supply Chain, External Manufacturing, Procurement, and more.

TraceLink Appoints Merck KGaA Thought Leader to Drive Strategy for Deployment of Advanced Analytics across Life Sciences Industry

TraceLink, which helps pharma companies trace drugs through the supply chain, just raised $93 million – TechCrunch

TraceLink, a nine-year-old, software-as-a-service platform for tracking pharmaceuticals and trying to weed out counterfeit prescription drugs in the process, has raised $93 million in Series D funding. Most of the money — $60 million — was used to buy primary shares, with another $33 mi…
Updated on: Jun 22, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.